8 completed, 8 recruiting, 5 not yet recruiting, 1 active not recruiting. 11 Not applicable, 5 Phase 2, 3 Phase 3.
Follow Human Papilloma Virus (HPV): new trials by email Literature Review of Human Papilloma Virus (HPV) trials Research Report on Human Papilloma Virus (HPV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Swabs in Screening for HPV (SWISH) Self-collected anal swab - Anal Cancer, Human Papilloma Virus (HPV) | Not applicable | Not yet recruiting | Kirby Institute | 700 | 2026-11-01 | 2026-08-27 |
| Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5) VP-102 - Common Warts, Common Warts (Verruca Vulgaris) | Phase 2 | Not yet recruiting | Verrica Pharmaceuticals Inc. | 30 | 2026-10-01 | 2026-10-20 |
| Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) Active Surveillance With ctHPVDNA (NavDx®) - Squamous Cell Carcinoma, Human Papilloma Virus (HPV) | Phase 2 | Recruiting | Medical University of South Carolina | 36 | 2026-08-12 | 2026-09-14 |
| A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV) Lopinavir / ritonavir - Human Papilloma Virus (HPV), High-risk Human Papillomavirus Infection | Phase 2 | Recruiting | Daré Bioscience, Inc. | 118 | 2026-07-17 | 2026-10-29 |
| Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia TICHILALECH ECHO - Cervical Carcinoma, Human Papilloma Virus (HPV) | Not applicable | Enrolling by invitation | Albert Einstein College of Medicine | 60 | 2026-06-24 | 2026-07-01 |
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) VP-102 (US) / TO-208 (Japan), Vehicle (US) / Vehicle (Japan) - Common Warts, Common Warts (Verruca Vulgaris) | Phase 3 | Recruiting | Verrica Pharmaceuticals Inc. | 300 | 2026-06-15 | 2026-09-03 |
| Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance. Papilocare Vaginal Gel - Womens Health, Cervical Dysplasia | Not applicable | Recruiting | University of Aarhus | 70 | 2026-06-09 | 2026-08-03 |
| HPV Testing as a Prevention of Cervical Dysplasia and Cancer Before Planned Subtotal Hysterectomy Cervical Cancer Screening, Human Papilloma Virus (HPV) | Not yet recruiting | General University Hospital, Prague | 300 | 2026-04-01 | 2026-04-22 | |
| Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris) Cantharidin - Common Warts (Verruca Vulgaris), Common Warts | Phase 3 | Recruiting | Verrica Pharmaceuticals Inc. | 250 | 2026-03-11 | 2026-10-22 |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) VP-102, Vehicle - Common Warts, Common Warts (Verruca Vulgaris) | Phase 3 | Active not recruiting | Verrica Pharmaceuticals Inc. | 302 | 2025-12-17 | 2026-10-23 |
| Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy Cervical Cancer, Human Papilloma Virus (HPV) | Recruiting | University of Florida | 55 | 2025-12-15 | 2026-02-12 | |
| Knowledge and Beliefs of Hearing Impaired Individuals Regarding Human Papillomavirus (HPV) HPV Card Game - Human Papilloma Virus (HPV), Hearing Disability | Not applicable | Not yet recruiting | Çankırı Karatekin University | 40 | 2025-09-28 | 2025-10-06 |
| Transmission of Oncogenic HPV Infection Among Families Human Papilloma Virus (HPV), Cervical Carcinoma | Not yet recruiting | Tampere University Hospital | 700 | 2025-08-01 | 2025-06-25 | |
| Unidos Contra el VPH Self-sampling with urine, Self-sampling with swab, In-clinic Pap/HPV co-testing - Human Papilloma Virus (HPV), Cervical Cancers | Not applicable | Recruiting | University of Texas at Austin | 735 | 2025-01-28 | 2026-06-10 |
| Impact of HPV Education on Knowledge, Awareness, and Concern HPV Education - Human Papilloma Virus (HPV) | Not applicable | Completed | Gizem ÇITAK | 103 | 2025-01-01 | 2025-08-08 |
| Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts Intralesional combined furosemide (10 mg/ml) and digoxin (0.25 mg/ml), Intralesional polidocanol 2% - Cutaneous Warts, Human Papilloma Virus (HPV) | Phase 2 | Completed | Benha University | 64 | 2024-09-01 | 2026-01-02 |
| Peer Education on HPV: Impact on Health Sciences Students' Knowledge, Awareness, and Concern peer education - Human Papilloma Virus (HPV) | Not applicable | Completed | Saglik Bilimleri Universitesi | 127 | 2024-05-01 | 2025-04-03 |
| Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic Salicylic Acid/Lactic Acid Topical Solution, Candida Antigen Intralesional Injection, Candida Antigen and Salicylic Acid/Lactic Acid - Warts, Human Papilloma Virus (HPV) | Phase 2 | Completed | Benha University | 126 | 2023-12-01 | 2026-08-04 |
| Human Papilloma Virus Awareness Intervention Safe and Protected Sex" intervention targeting HPV, Diptych of the Secretary of Health in Mexico - Human Papilloma Virus (HPV) | Not applicable | Completed | Hospital Univeristario Benemerita Universidad Autonoma de Puebla | 40 | 2021-12-01 | 2025-04-10 |
Showing 20 of 23. Sign in to see all of them.
Warts (5) · Uterine Cervical Neoplasms (4) · Chickenpox (2) · Adenoviridae Infections (1) · Anus Neoplasms (1) · Arenaviridae Infections (1) · Brucellosis (1) · Bunyaviridae Infections (1) · Caliciviridae Infections (1) · Carcinoma, Squamous Cell (1) · Chikungunya Fever (1) · Chlamydia Infections (1) · Communicable Diseases (1) · Dengue (1) · Elephantiasis, Filarial (1)
DNA Virus Infections (8) · Infections (8) · Virus Diseases (8) · Neoplasms (7) · Tumor Virus Infections (7) · Genital Diseases (6) · Neoplasms by Site (6) · Skin Diseases (6) · Skin Diseases, Infectious (6) · Skin and Connective Tissue Diseases (6) · Urogenital Diseases (6) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Genital Diseases, Female (5) · Papillomavirus Infections (5)
VP-102 (3) · Cantharidin (1) · Digoxin (1) · Lopinavir (1) · Motivational Interviewing (1) · Standard of Care (1) · Vaccines (1) · Watchful Waiting (1) · lactic acid, salicylic acid drug combination (1)
Verrica Pharmaceuticals Inc. (4) · Benha University (2) · University of Florida (2) · Albert Einstein College of Medicine (1) · Daré Bioscience, Inc. (1) · General University Hospital, Prague (1) · Gizem ÇITAK (1) · Hoffmann-La Roche (1) · Hospital Univeristario Benemerita Universidad Autonoma de Puebla (1) · Institut Pasteur du Cambodge (1) · Kirby Institute (1) · Medical University of South Carolina (1) · Saglik Bilimleri Universitesi (1) · Tampere University Hospital (1) · University of Aarhus (1)
United States (10) · Egypt (2) · Japan (2) · Turkey (Türkiye) (2) · Australia (1) · Cambodia (1) · Denmark (1) · Ethiopia (1) · Finland (1) · Mexico (1)
Adelaide A Hebert, MD (1) · Allison Kempe, MD, MPH (1) · Andrea Thurman, MD (1) · Bhishamjit Chera, MD (1) · Breanne Lott, PhD (1) · Catherine Behrens (1) · Claude Flamand, Ph.D. (1) · Dr Isobel Mary Poynten, MBBS, MPH, DCH PhD (1) · Ghada Shams (1) · Ghada Shams, MD (1) · Karolina Louvanto, Professor (1)
PMID 21865084, PMID 22566415, PMID 24122508, PMID 25667973
2025 (1), U01CA294799 (1), U01IP000129 (1)